Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Harvard Business School
Deloitte
Daiichi Sankyo
Queensland Health

Generated: July 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,889,144

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,889,144 protect, and when does it expire?

Patent 9,889,144 protects YONSA and is included in one NDA.

This patent has thirty-seven patent family members in twenty-one countries.

Summary for Patent: 9,889,144
Title:Abiraterone acetate formulation and methods of use
Abstract: Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
Inventor(s): Murphy; Maura (Philadelphia, PA), Nemeth; Paul (Philadelphia, PA), Bosch; H. William (Philadelphia, PA), Callahan; Matthew (Philadelphia, PA), Bhamidipati; Satya (Philadelphia, PA), Coleman; Jason (Philadelphia, PA), Hill; Christopher (Philadelphia, PA), Norret; Marck (Darlington, AU)
Assignee: iCeutica Inc. (Philadelphia, PA)
Application Number:15/645,895
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,889,144
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 9,889,144
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;

Drugs Protected by US Patent 9,889,144

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharma Global YONSA abiraterone acetate TABLET;ORAL 210308-001 May 22, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKesson
QuintilesIMS
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.